Pharma

Moderna, Merck’s personalised mRNA vaccine clears Phase 3 in melanoma

HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after.

Read More
Drugs Health Medical

Scientists find innocuous bacteria cause most hospital infections

HQ Team April 15, 2024: Superbugs are held responsible for most hospital-acquired infections, however, research delving into the genetic data of bacteria causing.

Read More